Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer

Archives of Surgery

Volumn 136, Issue 9, 2001, Pages 1059-1063

  Rahusen, Frans D ^a   Torrenga, Hans ^a   Van Diest, Paul J ^a   Pijpers, Rik ^a   Van Der Wall, Elsken ^a   Licht, Jappe ^a   Meijer, Sybren ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER LOCALIZATION; CANCER SIZE; CANCER STAGING; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENTINEL LYMPH NODE;

EID: 0034780499     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.136.9.1059     Document Type: Article

References (41)

1. Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection
2. Sentinel lymph node mapping in breast cancer
3. Sentinel lymphadenectomy in breast cancer
4. Sentinel lymph node biopsy and axillary dissection in breast cancer: Results in a large series
5. Lessons learned from 500 cases of lymphatic mapping for breast cancer
6. Sentinel lymphadenectomy for breast cancer: Experience with 180 consecutive patients: Efficacy of filtered technetium 99m sulphur colloid with overnight migration time
7. The implementation of the sentinel node biopsy as a routine procedure for patients with breast cancer
8. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer
9. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?
10. Sentinel lymph node biopsy with metastasis: Can axillary dissection be avoided in some patients with breast cancer?
11. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: A preliminary study
12. Improved axillary staging of breast cancer with sentinel lymphadenectomy
13. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer
14. The morphometric prognostic index is the strongest prognosticator in premenopausal lymph node-negative and lymph node-positive breast cancer patients
15. "Blind" multicenter evaluation of the prognostic value of DNA image cytometric and morphometric features in invasive breast cancer
16. Quality control in immunocytochemistry: Experiences with the oestrogen receptor assay
17. Pathological prognostic factors in breast cancer, I: The value of histological grade in breast cancer: Experience from a large study with longterm follow-up
18. The sentinel node in breast cancer: A multicenter validation study
19. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes
20. Histopathological workup of sentinel lymph nodes: How much is enough?
21. The routine histological investigation of axillary lymph nodes for metastatic breast cancer
22. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging
23. Pathological investigation of sentinel lymph nodes
24. Immunohistochemical detection of lymph-node metastases
25. Lymph node micrometastases from breast carcinoma: Reviewing the dilemma
26. Significance of axillary macrometastases and micrometastases in mammary cancer
27. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4), V: Significance of axillary nodal micro- and macrometastases
28. Re: Chu et al "do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?"
29. Sentinel node biopsy in 70 unselected patients with breast cancer: Increased feasibility by using 10 mCi radiocolloid in combination with a blue dye tracer
30. Sentinel lymphadenectomy for breast cancer in a community managed care setting
31. Occult axillary lymph node metastases in "node-negative" breast carcinoma
32. Prognostic importance of occult axillary lymph node micrometastases from breast cancers: International (Ludwig) Breast Cancer Study Group
33. Importance of tumor cells in axillary node sinus margins ("clandestine" metastases) discovered by serial sectioning in operable breast carcinoma
34. Occult axillary lymph node metastases in invasive breast carcinoma: Characteristics of the primary tumor and significance of the metastases
35. Detection and significance of occult axillary node metastases in patients with invasive breast cancer
36. Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis
37. Lymphatic mapping and sentinel lymph node biopsy in breast cancer
38. Technical details of intraoperative lymphatic mapping for early stage melanoma
39. Breast cancer patients treated without axillary surgery: Clinical implications and biologic analysis
40. Relation of tumor size, lymph node status, and survival in 24740 breast cancer cases
41. Tumor size and axillary metastasis, a correlative occurrence in 1244 cases of breast cancer between 1980 and 1995